baber/WOPTO huggingface dataset:
Patent SI-1282446-T1 (SI)
Title: Pharmaceutical and/or cosmetic composition containing an organosiloxane and a phospholipid
Inventor: PIOTROWIAK RALF
IPC: C05G3/60
Filed: 2001-04-14
Abstract: Use of phospholipid in a pharmaceutical and/or cosmetic composition for use in humans, animals or plants, comprising: (i) a pharmaceutical and/or cosmetic active ingredient; and (ii) organosilicon compounds based on oligomeric and/or polymeric diorganosiloxanes, is new. Pharmaceutical and/or cosmetic composition for use in humans, animals or plants, comprises: (i) at least a pharmaceutical and/or cosmetic active ingredient; and (ii) organosilicon compounds based on oligomeric and/or polymeric diorganosiloxanes. ACTIVITY : Virucide; Fungicide; Antibacterial; Dermatological; Neurological; Antibiotic; Analgesic; Antirheumatic; Anticoagulant; Thrombolytic; Antiallergic; Immunosuppressive; Vulnerary; Relaxant; Anticonvulsant; Antiparkinsonian; Antiemetic; Cardiant; Antiasthmatic; Antitussive; Hepatotropic; Cytostatic; Immunomodulatory; Nephrotropic. No biological data given.
Patent SI-1468615-T1 (SI)
Title: A food preparation with a creamy consistency for use as a base for sauces
Inventor: FESTA ADRIANO
IPC: A23L27/10
Filed: 2003-04-11
Abstract: A pasteurized foodstuff preparation of creamy consistency, to be used as a base for sauces, containing, in percentage of weight per total weight, 10 to 50% of edible fats, 30 to 70% of at least one organoleptically characterizing ingredient of vegetal origin, like for example, mushrooms and vegetables, characterized by a water activity (Aw) less than or equal to 0.95 and a pH lower than or equal to 5.0.
Patent SI-1603941-T1 (SI)
Title: Inhibitors of extracellular hsp90
Inventor: JAY DANIEL G
IPC: G01N33/50
Filed: 2004-03-09
Abstract: The present invention describes the inhibitors of extracellular Hsp90. The inhibition of extracellular Hsp90 leads to a reduction of the invasiveness of the tumor cells. Furthermore, the invention relates to the use of molecules inhibiting extracellular Hsp90 function for the manufacture of a medicament for the treatment or prevention of invasion and/or metastatic potential of cancer cells.
Patent SI-1891009-T1 (SI)
Title: A novel process for the preparation of lercanidipine
Inventor: PARTHASARADHI REDDY BANDI
IPC: C07D211/00
Filed: 2005-06-15
Abstract: The invention provides a novel process for the preparation of lercanidipine or a pharmaceutical acceptable salt using novel intermediates. Thus, 2,N-dimethyl-N-(3,3-diphenylpropy1)-1-amino-2-propanol is reacted with trimethylsilyl chloride in presence of triethyl amine in methylene chloride to give 2,N-dimethyl-2-(trimethylsilyloxy)-N-(3,3-diphenylpropy1)-1-propanamine, which is then reacted with 2,6-dimethyl-5-methoxycarbonyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3-carbonyl chloride for 2 hours and crystallized to obtain lercanidipine hydrochloride.
Patent SI-3065764-T1 (SI)
Title: Mini-gastrin analogue, in particular for use in cck2 receptor positive tumour diagnosis and/or treatment
Inventor: BEHE MARTIN
IPC: A61K38/00
Filed: 2014-10-23
Abstract: A gastrin analogue shows high uptake in CCK-2 receptor positive tumors and simultaneously a very low accumulation in the kidneys. This is achieved by a mini-gastrin analogue PP-F11 having the formula: PP-F11-X-DGlu-DGlu-DGlu-DGlu-DGlu-DGlu-Ala-Tyr-Gly-Trp-Y-Asp-Phe-NH2, wherein Y is an amino acid replacing methionine and X is a chemical group attached to the peptide for diagnostic and/or therapeutic intervention at CCK-2 receptor relevant diseases. Very suitable compounds with respect to a high tumor to kidney ratio are mini-gastrin analogues with six D-glutamic acids or six glutamines. These compounds still possess a methionine which can be oxidized easily which is a disadvantage for clinical application under GMP due to the forms which may occur. The elimination of the methionine leads to a lower affinity to oxidation which in general favors the tumor-kidney-ratio. Ideally, the methionine is replaced by norleucine. This PP-F11N mini gastrin exhibits currently the best tumor-kidney-ratio and is the most promising candidate.
Patent DE-3587496-T2 (DE)
Inventor: SCHOLL FREDERICK
IPC: H01L33/00
Filed: 1985-02-22
Granted: 1994-02-03
Abstract: A high efficiency edge-emitting LED is disclosed in which optical radiation produced in an active layer of the device leaves the device without being substantially absorbed by the material comprising the active layer. The device is constructed so that an optical waveguide is formed such that light produced in the active layer either leaves the device without any reflections or with a maximum of one reflection. The thickness of the active layer and the compositions of the active layer and confining layers are chosen so that electrical carriers are confined in the active layer while light produced in the active layer is not confined therein.
Patent DE-3751478-T2 (DE)
Inventor: LUBER JOSEPH
IPC: A61K33/08
Filed: 1987-03-05
Granted: 1996-03-21
Abstract: A process for the preparation of a viscosity-stable antacid composition containing an alginic acid salt comprising reacting an antacid material with said salt at elevated temperatures to form a reaction product and recovering said reaction product in stabilized form.
Patent DE-3782551-T2 (DE)
Inventor: WILLIAMS ROBERT D
IPC: A61K31/35
Filed: 1987-06-05
Granted: 1993-04-08
Abstract: The antibiotics carriomycin and lysocellin and their pharmaceutically acceptable salts and esters may be administered to swine to prevent or control swine dysentery.
Patent DE-3855513-T2 (DE)
Inventor: VON BORSTEL REID
IPC: A61K8/00
Filed: 1988-10-27
Granted: 1997-01-09
Abstract: Use of acyl derivatives of deoxyribonucleosides in manufacture of a medicament for enhancing haematopoesis or enhancing healing of bone marrow. <IMAGE>
Patent DE-3856251-T2 (DE)
Inventor: SUGIMOTO HACHIRO
IPC: C07D405/04
Filed: 1988-06-22
Granted: 1999-03-18
Abstract: Cyclic amine cpds. of formula (I) and their salts are new. - J is (a) a gp., opt. substd., of: phenyl, pyridyl, pyrazyl, cyclohexyl, quino(xa)lyl or furyl; (b) a monovalent or divalent gp., where the phenyl may have substit(s), of: indan(ol)yl, (iii) inden(on)yl, indan(edio)hyl, tetralonyl, benzosuberonyl, or C6H5-CO-CH(CH3)-; (c) a monovalent gp. derived from a cyclic amide cpd. (d) lower alkyl; or (e) R21-CH=CH- (R21 = H or (lower alkoxycarbonyl). B = (CHR22)r, CO(CHR22)r, NR4-(HCR22)r, CO-NR5-(CHR22)r, CH=CH-(CHR22)r, OCOO-(CHR22)r, OOC-NH-(CHR22)r, NH-CO-(CHR32)4, CH2CONH-(CHR22)r, (CH2)2CONH-(CHR22)r, CH(OH)-(CHR22)r, CH(OH)-(CHR22)r, = (CH-CH=CH)b, =CH-(CH2)c, =(CH-CH)d, COCH=CH-CH2, COCH2-CH(CH(OH)CH2, CH(CH3)CONHCH2, CH=CHCONH(CH2)2, NH, O, S, dialkylaminoalkylcarbonyl or lower alkoxycarbonyl; R4 = H, acyl, lower alkyl(sulphonyl), (substd.)phenyl, or (substd.)benzyl; R5 = H, lower alkyl or phenyl, r = 0-10; R22 = H or Me such that one alkylene may have no CH3 or one or more CH3; b = 1-3; c = 0-9; d = 0-5; T = N or C (i) Q = N, C or (i) q = 1-3; K = H, (substd.) phenyl, arylalkyl in which the phenyl may be substd. cinnamyl, lower alkyl, pyridylmethyl, cyclo(alkyl)alkyl, adamantanemethyl, furylmethyl, lower alkoxycarbonyl or acyl; and dotted lines is a single-or double-bond. - 1-benzyl-4-((5,6-dimethoxy -1-indanon)- 2-ylidenyl)methyl) piperidine hydrochlorideis and example.
Patent DE-3889005-T2 (DE)
Inventor: NEWKIRK MARC STEVENS
IPC: C04B37/00
Filed: 1988-05-19
Granted: 1994-09-08
Abstract: Two or more ceramic bodies (10,12) are bonded together by oxidizing with a vapor-phase oxidant molten metal obtained from a body of precursor metal (14) to form an oxidation reaction product bond. The oxidation reaction product is formed between adjacent facing, substantially congruent surfaces of the ceramic bodies (10,12) and bridges the surfaces, thus bonding the ceramic bodies (10,12) to each other. Promoters may optionally be used to facilitate formation of the oxidation reaction product.
Patent TR-199900307-T2 (TR)
Inventor: MUKHOPADHYAY DEBASISH
IPC: C02F1/42
Filed: 1997-08-12
Abstract: Sertlik ve hidroksit olmayan alkaliteyi bir zayif asit katyon degistirme reçinesinde gidermek amaciyla, diyaframli ayrica suyun aritilmasi sürecidir. Süreç, pH degerini 10.5 ya da üzerine ayarlamak suretiyle silis gibi düsük iyonlanabilen bilesenlerin iyonlanmasini içermektedir. Bu bilesenlerin diyaframla ayrilmasi önemli ölçüde arttirilmistir. Bor, silis ve TOK' larin geçisi on kati ya da daha fazla azaltilmistir. Aci besleme sularinin çogu ile %90 ya da üzerinde bir geri kazanim mümkün olup, ayni anda, temizleme sikliklarinda da önemli ölçüde azalma saglanmistir. Su aritma süreci cihazinda, ters osmoz diyafram(lar)i (30), karma yatakli iyon degistirme ünitesi (44,46), mikron filtre (48), ultraviyole sterilizasyon ünitesi (49), karbon giderme ünitesi (20) ve elektroiyonsuzlastirma ünitesi (150) bulunmaktadir.
Patent DE-60000065-T2 (DE)
Inventor: THOMAS ROGER
IPC: A01D34/74
Filed: 2000-07-10
Granted: 2002-07-18
Abstract: A lawn mower comprising a deck (2) mounted on at least two wheel assemblies (4), the deck (2) being mounted on each wheel assembly (4) via a height adjustment mechanism; an interconnecting bar (38) which connects between at least two of the height adjustment assemblies though which movement of one height adjustment mechanism is transferred to the other height adjustment mechanism so that the two height adjustment mechanisms operate in unison; a rack mounted on the interconnecting bar; and a locking mechanism which is capable of co-operating with the rack to hold interconnecting bar stationary relative to the deck, wherein the locking mechanism comprises a pinion (104) rotatably mounted on the deck (2) which meshes with the rack (100) and which is capable of being releasably locked in a plurality of angular positions. The pinion (104) is capable of axially sliding between a first position where it is prevented from rotation movement and a second position where it is capable of freely rotating whilst remaining meshed with the rack (100). The pinion (104) is biased towards the first position and may be moved by a cam mechanism.  <IMAGE>
Patent DE-60006375-T2 (DE)
Inventor: GLEYZES YVES-PAUL
IPC: H04B7/185
Filed: 2000-05-10
Granted: 2004-09-09
Abstract: A bidirectional multimedia communication terminal with two orientable antennas for sending/receiving radio signals conveying multimedia data, electronic signal processors for processing signals received/sent via the antennas, a pointing system for pointing each antenna at a predetermined satellite from a constellation of non-geostationary satellites forming part of a multimedia telecommunication system, and a switching system for selectively switching the transmission of multimedia data between the terminal and the satellites of the constellation from the satellite at which one of the antennas is pointed to the satellite at which the other antenna is pointed. The pointing system includes an antenna orientation unit associated with each antenna and a control unit for controlling the orientation units on the basis of data on the position of the terminal in a frame of reference tied to the Earth and on ephemerides of visible satellites of the constellation.
Patent DE-60014344-T2 (DE)
Inventor: TUCKMANTEL WERNER
IPC: C07C311/62
Filed: 2000-03-29
Granted: 2006-03-09
Abstract: Novel catechin and epicatechin dimers with (8+Z 8), (6+Z 6), and (8+Z 6) linkages are prepared, as well as digallated dimers. A novel process for preparing these compounds is disclosed which involves the oxidative or reductive coupling of protected monomers.
Patent DE-60015760-T2 (DE)
Inventor: GAUTIER JEAN
IPC: A61M5/14
Filed: 2000-04-18
Granted: 2005-11-10
Abstract: The invention concerns a device for injecting entirely products which, when they stagnate in the tubing are often thrown away therewith, thereby causing the patient to be insufficiently treated and environmental risks. The device consists of: a fixed three-way valve (3) enabling the rinsing syringe (13) to be permanently screwed (5); a tapered base (12) on the lower part of the air chamber (7), whereon a plastic ball (10) is urged to seal the discharge tubing (9). Said ball (10) is guided by a small perforated tube (11), which is itself soldered on the tapered base (12). The inventive device is particularly designed for all slow intravenous chemotherapy perfusions (IVL): antimitotic for the treatment of cancers, but also antibiotic, anaesthetic and valuable blood products such as blood platelets. By extension, it is also useful for similar veterinary products.
Patent DE-60019783-T2 (DE)
Inventor: HEIKKILAE PERTTI
IPC: D21F9/00
Filed: 2000-10-26
Granted: 2006-01-19
Abstract: At the end of the twin wire zone of a paper machine former, a suction box ( 17 ) inside the upper wire loop ( 11 ) has a curved lid ( 17 ') opposite a roll ( 18 ) within the lower wire loop ( 10 ). The lid is curved in a run situation so the tension of the upper wire ( 11 ) reduces the normal force between the wire ( 11 ) and the lid ( 17 ') caused by the underpressure of the suction box. The underpressure keeps the web mainly off from the roll ( 18 ) and the lower wire ( 10 ) while being adhered to the underside of the upper wire ( 11 ) and conforming to the curved shape of the lids. Members ( 17 a , 18 ') are provided for making the web follow the lower wire ( 10 ) in a break situation for conducting it to the broke handling system.
Patent DE-60019894-T2 (DE)
Inventor: FLOCKERZI DIETER
IPC: A61P11/04
Filed: 2000-01-13
Granted: 2006-01-12
Abstract: The N-oxides of the compounds of formula (I), in which R1, R2, R3, R31, R4, R5, R51 and R6 have the meanings indicated in the description, are novel active bronchial therapeutics.
Patent DE-60023315-T2 (DE)
Inventor: FEENSTRA KORNELIS
IPC: B29C64/112
Filed: 2000-08-24
Granted: 2006-08-24
Abstract: The present invention relates to a method for fabricating a functional dental element, such as a crown. According to the invention, use is made of a three-dimensional printing technique. The major advantages of the invention are that no mold is needed anymore, which entails a considerable saving of costs, that a great accuracy is achieved, and that the element can be made of different materials.
Patent DE-60024771-T2 (DE)
Inventor: METELLI LUIGI
IPC: E04B7/02
Filed: 2000-08-02
Granted: 2006-09-14
Abstract: The invention concerns a girder in reinforced concrete that has a flat intrados (11) and a flat or sloping extrados (12), which consists of two symmetrical halves or girders (13, 14) with adjacent parts that meet in a plane mid-way (15), perpendicular to the intrados, and equipped, near the extrados (12), with connecting plates for bolting (16) and, near the intrados (11), with a joint device (17) that has bars which are parallel to the intrados.
Patent DE-60027737-T2 (DE)
Inventor: SILVERBROOK KIA
IPC: B41J2/21
Filed: 2000-05-24
Granted: 2006-11-23
Abstract: A modular camera and printer is disclosed. A camera module is provided having an image sensor for capturing an image in a RGB format. The camera module also has a central processing unit with program memory for storing program steps for execution by the central processing unit to operate the camera module, and an image storage memory for storing the captured image in the RGB format. An image processing unit of the camera module is in communication with the image storage memory and transforms image data in the image storage memory into a L*a*b* format. The camera module also has a serial bus for outputting transformed image data in the L*a*b* format. A printer module is provided also having a serial bus in communication with the serial bus of the camera module. The printer module receives the image data from the camera module in the L*a*b* format, converts the image data to a color space of the printer module, and then prints the image data on a printhead.
Patent DE-60027749-T2 (DE)
Inventor: BAXTER DAVID
IPC: A61P21/00
Filed: 2000-10-13
Granted: 2007-05-03
Abstract: The present invention makes available methods and reagents for inhibiting aberrant growth states resulting from <i>hedgehog</i> gain-of-function, <i>ptc</i> loss-of-function or <i>smoothened</i> gain-of-function comprising contacting the cell with a <i>hedgehog</i> antagonist, such as a small molecule, in a sufficient amount to aberrant growth state, e.g., to agonize a normal <i>ptc</i> pathway or antagonize <i>smoothened</i> or <i>hedgehog</i> activity.
Patent DE-60032354-T2 (DE)
Inventor: SQUIRRELL DAVID JAMES
IPC: G01N33/483
Filed: 2000-05-09
Granted: 2007-09-27
Abstract: A method for detecting the presence of eukaryotic cells in a sample of a normally cell-free body fluid, said method comprising lysing any cells present in the sample, and then (i) adding adenosine diphosphate (ADP) to said sample under conditions which allowss the conversion of ADP to adenosine triphosphate (ATP) by cellular adenylate kinase, (ii) detecting ATP in said sample and relating that to the presence of adenylate kinase and thus to the presence of lysed cells.  The method is useful for detecting the presence of cells in samples such as milk or urine for diagnostic purposes.
Patent DE-60033549-T2 (DE)
Inventor: ANDRINGA TJEERD CATHARINUS
IPC: G01R23/175
Filed: 2000-11-06
Granted: 2007-11-22
Abstract: A basilar membrane model is used to receive an input signal including a target signal in step I. With successive further steps the target signal is filtered from the input signal. After the filtering the target signal can be used as an input for further processing, like for example signal recognition of data compression. The target signal can also be applied to a substantially reverse method to be obtain an improved or clean signal.
Patent DE-60035439-T2 (DE)
Inventor: WANG RUI
IPC: H04L1/06
Filed: 2000-12-20
Granted: 2007-10-31
Abstract: A differential space-time block coder produces successive space-time blocks of symbols from M-PSK symbols to be encoded, in accordance with an orthogonal matrix and a normalization factor. Differentially encoded space-time output blocks, for transmission via a plurality of transmit antennas (16, 18) of a wireless communications system, are produced by multiplying (42) each space-time block from the space-time block coder (40) by the respective previous (44) differentially encoded space-time output block. Decoding is independent of channel estimation, and the arrangement is simple, avoids error propagation, and is applicable to different numbers of transmit antennas.
Patent DE-60115434-T2 (DE)
Inventor: SCHORN MARTIN
IPC: C13B30/02
Filed: 2001-05-30
Granted: 2006-06-14
Abstract: A continuous vacuum pan includes a cylindrical housing having a vertical axis, at least one liquid heating pan within the housing, and a vertical tube, floating calandria within the liquid heating pan. The vertical tube floating calandria has a downcomer between its periphery and the periphery of the liquid heating pan, and a gap is provided between the bottom of the calandria and the bottom of the liquid heating pan. Radially extending baffles in the liquid heating pan define a plurality of compartments located in series with one another, the compartments ranging from a first upstream compartment to a downstream output compartment. Ports are provided in all of the baffles except in the baffle between the output compartment and the first compartment. The ports are spaced from the bottom of the liquid heating pan, permitting communication between the compartments.
Patent DE-60115514-T2 (DE)
Inventor: JINNAI YASUAKI
IPC: F01D17/16
Filed: 2001-01-24
Granted: 2006-08-10
Abstract: Variable nozzle drive mechanism with a link plate (112), which can operate all the nozzle vanes smoothly and synchronously. The nozzle vanes (104) are supported in such a way that the nozzle vanes are free to rotate between the open and closed positions on nozzle shafts (104a), and the nozzle vanes (104) are connected to levers (114) which correspond to the nozzle shafts (104a) so as to rotate along with the levers (114). Each boss (114a) at the end of each lever (114) functions as a shaft which are parallel to the nozzle shaft. The shafts (114a) in the nozzle vanes engage in oblong holes (114a) in the link plate (112) in such a way that they are free to swing, and are thereby connected to the link plate. The declined straight or curved centerline which runs the oblong hole to the oblong direction, extends at a given angle with respect to the radius of the link plate. <IMAGE>
Patent DE-60120650-T2 (DE)
Inventor: BERTOZZI CAROLYN
IPC: C07K1/02
Filed: 2001-03-16
Granted: 2007-05-31
Abstract: The present invention features a chemoselective ligation reaction that can be carried out under physiological conditions. In general, the invention involves condensation of a specifically engineered phosphine, which can provide for formation of an amide bond between the two reactive partners resulting in a final product comprising a phosphine moiety, or which can be engineered to comprise a cleavable linker so that a substituent of the phosphine is transferred to the azide, releasing an oxidized phosphine byproduct and producing a native amide bond in the final product. The selectivity of the reaction and its compatibility with aqueous environments provides for its application in vivo (e.g., on the cell surface or intracellularly) and in vitro (e.g., synthesis of peptides and other polymers, production of modified (e.g., labeled) amino acids).
Patent DE-60121337-T2 (DE)
Inventor: WAITE MICHAEL
IPC: C02F1/461
Filed: 2001-07-18
Granted: 2007-07-05
Abstract: A process for increasing the active surface area of at least one electrode having a surface comprising a group VIII metal in an electrochemical cell, which also comprises at least one balancing electrode and an aqueous electrolyte which comprises nitrate ions, which comprises applying a sweeping voltage across the electrodes at a rate of at least 0.2 V/s, the sweeping voltage being from a lower voltage which is between the voltage at which hydrogen evolution occurs and -0.7 V to an upper voltage which is between -0.2 V and +0.3 V, all of the above voltages being with reference to a standard calomel reference electrode (VSCE).
Patent DE-60130457-T2 (DE)
Inventor: HEUSER RICHARD R
IPC: A61B17/11
Filed: 2001-07-02
Granted: 2008-06-19
Abstract: A catheter apparatus is provided including an arterial catheter and a venous catheter wherein the distal ends of the catheter are insertable in an artery and a adjacent vein, respectively to a position adjacent a site for creating a fistula. The venous catheter includes a radially expandable structure adjacent the distal end which can be selectively extended outwardly to expand a portion of the wall of the vein adjacent the venous fistula site towards contact with the wall of the artery adjacent the arterial fistula site. The radially expandable structure of the venous catheter may include one or more balloons which can be inflated or a wire basket, or the vein can be expanded by injecting a fluid through an injection port into an isolated portion of the vein. The apparatus further includes a tool for creating an opening through the wall of the artery adjacent the arterial fistula site and an opening through the outwardly extending portion of the wall of the vein adjacent the venous fistula site to extend outwardly the portion of the wall of the vein towards contact with the wall of the artery. The tool may include a needle coupled to the arterial catheter adjacent the distal end of the arterial catheter, the needle being selectively switchable between a first, inactive configuration wherein the needle can be guided through the artery without causing trauma to the artery wall and a second, active configuration wherein the needle is operative to create the opening in the artery wall. The fistula between the openings may be completed with the aid of a stent, and the proximal portion of the vein blocked with an embolization device.